Entries by Dr. Emmanuel Egbroko

PHARMACISTS IN FRANCE CAN NOW PRESCRIBE AND ADMINISTER VACCINES

  According to a publication in Vaccines Today, in France, trained pharmacists will be permitted to prescribe and administer vaccines.   Pharmacists played a major role in the uptake of the COVID-19 vaccines, and they’ve been granted permission to administer shots against diphtheria, tetanus, polio, pertussis, flu, HPV, measles, mumps, rubella, hepatitis A, hepatitis B, […]

COURT DISMISSES APPLICATION AIMED AT PREVENTING PHARMACISTS FROM PRESCRIBING ANTIRETROVIRAL MEDICINES IN SOUTH AFRICA

  A Pretoria High Court dismisses application brought by a physician association (IPA Foundation) that aimed at preventing pharmacists from managing and prescribing medicines to patients with HIV and tuberculosis.    The approval means Patients Living With HIV (PLWH) will have increased access to their medicines at pharmacies that are taking part in the Pharmacy […]

WHAT YOU SHOULD KNOW ABOUT PAXLOVID AND LONG COVID

  Research findings says people who took Paxlovid are less likely to have long COVID symptoms. The article was published in March 2023 in JAMA Internal Medicine. It revealed that high-risk patients who took Paxlovid within five days of confirming infection for COVID-19 were 26% less likely to have Long COVID symptoms after 90 days, compared […]

WHAT YOU SHOULD KNOW ABOUT PAXLOVID APPROVAL

   Jennifer Lorenzini/Reuters   The U.S Food and Drug Administration (FDA) approves Paxlovid for the treatment of mild-to-moderate COVID-19. In a press release On May 25, 2023, the FDA granted Pfizer approval for its antiviral medication for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including […]